The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
about
Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cellsA comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsRecent advancements in erythrocytes, platelets, and albumin as delivery systemsNew Strategies for the Treatment of Solid Tumors with CAR-T CellsLipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseImproving the clinical impact of biomaterials in cancer immunotherapy.Onto better TRAILs for cancer treatmentRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingPhotodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesSite-specific functionalization of proteins and their applications to therapeutic antibodiesCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesModulation of the tumor microenvironment for cancer treatment: a biomaterials approachImproving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?Gold nanoparticles as novel agents for cancer therapyEGF receptor-targeted nanocarriers for enhanced cancer treatmentMathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survivalQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingImproving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet Vaporization.EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumorsStealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.Molecular imaging for cancer diagnosis and surgery.The potential of polymeric micelles in the context of glioblastoma therapy.Exploring the tumor microenvironment with nanoparticlesCancer nanomedicine: from targeted delivery to combination therapyDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersConvergence of nanotechnology and cancer prevention: are we there yet?Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier modelsDesign and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agentRealizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concernsChemophototherapy: An Emerging Treatment Option for Solid TumorsCellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticlesQuantitative Analysis of the Enhanced Permeation and Retention (EPR) EffectDesign strategies and applications of circulating cell-mediated drug delivery systemsXTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based CytostaticLong-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In VitroTheranostic nanoparticlesMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesTheranostic Performance of Acoustic Nanodroplet Vaporization-Generated Bubbles in Tumor Intertissue.
P2860
Q23917422-90ED0C3F-29A2-42BD-AAA9-3F6503B13D49Q26744352-66135602-468A-4CE1-AAE3-E777524E3019Q26747764-6B8EC9C2-AA41-400C-B030-8D2B38CCB4A5Q26748500-BE14556D-C7D2-4AC2-A0EC-B449128F94A2Q26752578-CCDEE02D-D426-4CA5-BB52-4F202585A4F6Q26766267-E39D0105-8939-4FCD-8DCD-BF9BDBBD3B9EQ26768160-1DAEE43B-B2AD-4266-A4C6-CFC73AA02D91Q26778234-ED25CFEA-F32C-465E-8EB9-E24800A1537FQ26827820-4B11C08E-A69D-483F-90D1-B4E3AE6BAD0EQ26830699-F1EAE7EB-E994-478D-B792-35BA47E43E2FQ26863779-C3A82700-3370-4B16-8D75-2280F3950CAFQ26996790-9D7D4421-D0CB-4AFF-A025-4996665463B8Q26999332-AC5AA15C-44CE-42E8-AEA3-4D0B0A09B7DFQ27008020-772BD2ED-7373-4029-B30C-61A802D581A3Q27013001-4184A444-2EBD-4829-91C3-3AD304A75FE3Q27023583-F5AAE899-4F05-44A4-8779-F9C13837605CQ27023605-6CEB8DDE-F7C7-4DED-8773-4C43FCEE0786Q27300853-7154CCB7-6048-4E04-B6B1-68F35AC83711Q27318449-37074FED-6934-4043-9B9C-B47C3D9073F5Q27334548-1FB185B9-A620-45AD-B584-F47DCD5CD305Q27334823-3EF8090D-7AE6-42A8-88E1-E77BE55E9578Q27335339-3A333AD9-9319-4CAC-8105-E2A2E1316212Q27687291-C0ED4A88-E9A1-4B79-8712-3E34A70C8314Q27693205-59580771-C560-411A-8349-32D5AD1FE377Q28082374-6099F6B6-DFBA-4F42-AD43-98DDD2AAB165Q28083065-6B48B23B-A492-42EB-A208-5D9954803200Q28283802-CE8D6ADB-5487-4FC9-AA67-D9B0610E1CDFQ28386699-2A5396F4-B27B-4EEE-9A8D-0DC7279BAAE9Q28392542-DD73E8E6-1B50-4ED5-B4C1-CE72906F007EQ28396437-B7C1F4EB-9515-47CB-A94A-B83B27FE14C9Q28396462-28D3AF60-6C6D-414E-9248-0E9810A9119EQ28468315-505F5BD3-DF8E-4556-AD5C-728B7EB57B70Q28538811-A8AB025F-A2A0-491C-8477-795ED19D1B71Q28547003-68133871-1580-466D-955B-3904179BDEA7Q28547179-953CA6F6-88DC-4F78-82D9-E5E18F64BB96Q28550226-6DCE999D-18B9-4C3B-8AC9-1F4C8950AD3EQ28554939-870233B4-6649-40B3-93FB-B1B16AEB7809Q28650348-147A4E31-E108-4629-B220-E0B65BE0C161Q30354223-024980AE-9CB2-4130-B3D8-3D91E73753ACQ30356036-DC099C27-9C08-49E1-85E4-EA4BBF973551
P2860
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The EPR effect: Unique feature ...... nd augmentation of the effect.
@en
The EPR effect: Unique feature ...... nd augmentation of the effect.
@nl
type
label
The EPR effect: Unique feature ...... nd augmentation of the effect.
@en
The EPR effect: Unique feature ...... nd augmentation of the effect.
@nl
prefLabel
The EPR effect: Unique feature ...... nd augmentation of the effect.
@en
The EPR effect: Unique feature ...... nd augmentation of the effect.
@nl
P2093
P1476
The EPR effect: Unique feature ...... nd augmentation of the effect.
@en
P2093
Hideaki Nakamura
Hiroshi Maeda
P304
P356
10.1016/J.ADDR.2010.04.009
P407
P577
2010-05-02T00:00:00Z